SCHEMBL10154532

SCHEMBL10154532

CC(C)[C@H](O[Si](c1ccccc1)(c1ccccc1)C(C)(C)C)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CYP2D6 P10635 1/20 0.37
PPARG P37231 2/20 0.37
PPARA Q07869 2/20 0.37
KMT2A Q03164 2/20 0.36
TP53 P04637 1/20 0.36
TSHR P16473 1/20 0.36
PTGS2 P35354 1/20 0.35
PTGS1 P23219 1/20 0.33
ALOX5 P09917 1/20 0.33
SRC P12931 1/20 0.33
MEN1 O00255 1/20 0.33
CYP1A2 P05177 1/20 0.33
GAA P10253 1/20 0.33
CYP2C9 P11712 1/20 0.33
PKM P14618 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1928940 1.00 ATM (0.37) ATML3MBTL1CYP2D6PPARGPPARA
SCHEMBL4188849 0.92 CYP2D6 (0.41) ATML3MBTL1CYP2D6KMT2ATP53
SCHEMBL1926988 0.83 KMT2A (0.41) ATML3MBTL1CYP2D6KMT2APTGS2
SCHEMBL1487233 0.83 KMT2A (0.41) ATML3MBTL1CYP2D6KMT2APTGS2
SCHEMBL1927300 0.83 KMT2A (0.41) ATML3MBTL1CYP2D6KMT2APTGS2
SCHEMBL4180791 0.83 KMT2A (0.47) ATML3MBTL1CYP2D6KMT2ATSHR
SCHEMBL7572490 0.83 KMT2A (0.47) ATML3MBTL1CYP2D6KMT2ATSHR
SCHEMBL5873085 0.81 PTGS2 (0.35) ATML3MBTL1CYP2D6KMT2APTGS2
SCHEMBL8892064 0.81 PTGS2 (0.35) ATML3MBTL1CYP2D6KMT2APTGS2
SCHEMBL29525590 0.78 ALOX5 (0.38) CYP2D6KMT2APTGS2ALOX5MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150210680-A1 AMINODIHYDROTHIAZINE DERIVATIVES SHIONOGI & CO (JP) 2015-07-30 US disclosed
US-9029358-B2 Aminodihydrothiazine derivatives SHIONOGI & CO., LTD. (JP) 2015-05-12 US disclosed
US-8895548-B2 Pharmaceutical composition for treating alzheimer's disease SHIONOGI & CO., LTD. (JP) 2014-11-25 US disclosed
US-8815851-B2 Aminodihydrothiazine derivatives SHIONOGI & CO., LTD. (JP) 2014-08-26 US disclosed
US-20140058097-A1 PHARMACEUTICAL COMPOSITION FOR TREATING ALZHEIMER'S DISEASE SHIONOGI & CO., LTD. (JP) 2014-02-27 US disclosed
US-8653067-B2 Pharmaceutical composition for treating Alzheimer's disease SHIONOGI & CO., LTD. (JP) 2014-02-18 US disclosed
US-8633188-B2 Aminodihydrothiazine derivatives SHIONOGI & CO., LTD. (JP) 2014-01-21 US disclosed
US-20130303755-A1 AMINODIHYDROTHIAZINE DERIVATIVES SHIONOGI & CO (JP) 2013-11-14 US disclosed
US-8546380-B2 Aminodihydrothiazine derivatives SHIONOGI & CO., LTD. (JP) 2013-10-01 US disclosed
US-20130158260-A1 AMINODIHYDROTHIAZINE DERIVATIVES SHIONOGI & CO., LTD. (JP) 2013-06-20 US disclosed
US-8173642-B2 Aminodihydrothiazine derivatives SHIONOGI & CO., LTD. (JP) 2012-05-08 US disclosed
US-20120022249-A1 AMINODIHYDROTHIAZINE DERIVATIVES SHIONOGI & CO., LTD. (JP) 2012-01-26 US disclosed
US-20120016116-A1 AMINODIHYDROTHIAZINE DERIVATIVES SHIONOGI & CO., LTD. (JP) 2012-01-19 US disclosed
US-20100160290-A1 PHARMACEUTICAL COMPOSITION FOR TREATING ALZHEIMER'S DISEASE SHIONOGI & CO., LTD. (JP) 2010-06-24 US disclosed
US-20090082560-A1 AMINODIHYDROTHIAZINE DERIVATIVES SHIONOGI & CO., LTD. (JP) 2009-03-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120016116-A1 AMINODIHYDROTHIAZINE DERIVATIVES BACE1, BACE2, APP ATM 3711/4885L3MBTL1 3240/4885CYP2D6 310/4885
US-20100160290-A1 PHARMACEUTICAL COMPOSITION FOR TREATING ALZHEIMER'S DISEASE NR1H2, NR1H3, NR0B1 ATM 3039/4885L3MBTL1 4609/4885CYP2D6 379/4885
US-20130158260-A1 AMINODIHYDROTHIAZINE DERIVATIVES BACE1, BACE2, APP ATM 3985/4885L3MBTL1 2393/4885CYP2D6 592/4885
US-20140058097-A1 PHARMACEUTICAL COMPOSITION FOR TREATING ALZHEIMER'S DISEASE NR1H2, NR1H3, NR0B1 ATM 3089/4885L3MBTL1 4622/4885CYP2D6 387/4885
US-20130303755-A1 AMINODIHYDROTHIAZINE DERIVATIVES BACE1, BACE2, APP ATM 3711/4885L3MBTL1 3240/4885CYP2D6 310/4885
US-20120022249-A1 AMINODIHYDROTHIAZINE DERIVATIVES BACE1, BACE2, APP ATM 3711/4885L3MBTL1 3240/4885CYP2D6 310/4885
US-20150210680-A1 AMINODIHYDROTHIAZINE DERIVATIVES BACE1, BACE2, APP ATM 3711/4885L3MBTL1 3240/4885CYP2D6 310/4885
US-20090082560-A1 AMINODIHYDROTHIAZINE DERIVATIVES BACE1, BACE2, APP ATM 3711/4885L3MBTL1 3240/4885CYP2D6 310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.